Park, Y.C.; Seol, E.; Lee, J.; Hong, J.H.; Jung, J.-G.; Sunwoo, J.
Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 Study. Pharmaceutics 2025, 17, 1517.
https://doi.org/10.3390/pharmaceutics17121517
AMA Style
Park YC, Seol E, Lee J, Hong JH, Jung J-G, Sunwoo J.
Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 Study. Pharmaceutics. 2025; 17(12):1517.
https://doi.org/10.3390/pharmaceutics17121517
Chicago/Turabian Style
Park, Ye Chan, Eunyoung Seol, Jongmi Lee, Jang Hee Hong, Jin-Gyu Jung, and Jung Sunwoo.
2025. "Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 Study" Pharmaceutics 17, no. 12: 1517.
https://doi.org/10.3390/pharmaceutics17121517
APA Style
Park, Y. C., Seol, E., Lee, J., Hong, J. H., Jung, J.-G., & Sunwoo, J.
(2025). Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 Study. Pharmaceutics, 17(12), 1517.
https://doi.org/10.3390/pharmaceutics17121517
